• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Andrea Gallamini, Martin Hutchings, +17 authors Alessandro Levis
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2007 (First Publication: 20 August 2007)
  • PURPOSE Starting from November 2001, 260 newly diagnosed patients with Hodgkin's lymphoma (HL) were consecutively enrolled in parallel Italian and Danish prospective trials to evaluate the prognosticContinue Reading
  • Philip Went, Claudio Agostinelli, +11 authors Stefano A Pileri
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2006 (First Publication: 1 June 2006)
  • PURPOSE Although peripheral T-cell lymphoma, unspecified (PTCL/U), is the most common T-cell tumor in Western countries, no study to date has been based on the application of a wide panel of markersContinue Reading
  • Martin Dreyling, Catherine Thieblemont, +13 authors Emanuele Zucca
  • Medicine
  • Annals of oncology : official journal of the…
  • 2013 (First Publication: 1 April 2013)
  • To complement the existing treatment guidelines for all tumour types, ESMO organizes consensus conferences to focus on specific issues in each type of tumour. In this setting, a consensus conferenceContinue Reading
  • Andrea Gallamini, Francesco Zaja, +13 authors Corrado Tarella
  • Medicine
  • Blood
  • 2007 (First Publication: 1 October 2007)
  • To evaluate in a prospective multicenter trial the feasibility and clinical efficacy of the combination of alemtuzumab (Campath-1H) with the cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP)Continue Reading
  • Emmanuel Itti, Michel Meignan, +8 authors Corinne Haioun
  • Medicine
  • European Journal of Nuclear Medicine and…
  • 2013 (First Publication: 7 May 2013)
  • PurposeThe role of interim PET/CT in guiding therapeutic strategies in diffuse large B-cell lymphoma (DLBCL) is debated, mainly because interpretation rules vary among centres. This study aimed toContinue Reading
  • Giuseppe Todeschini, S Secchi, +21 authors Giovanni Pizzolo
  • Medicine
  • British Journal of Cancer
  • 2004 (First Publication: 20 January 2004)
  • The optimal treatment of primary mediastinal large B-cell lymphoma (PMLBCL) is still undefined. In the absence of randomised studies, we retrospectively analysed: (a) the effectiveness of twoContinue Reading